NOTCH3 and cerebral small vessel disease: As a result, CADASIL can now be definitively diagnosed through genetic testing of NOTCH3 or detection of GOM in skin biopsy specimens, consistent with the first guideline on the diagnosis and management of cerebral small vessel diseases recently proposed by the European Academy of Neurology [16].